Follow-up of PAP treated OSA patients in their home environment – a comparative study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00007705

Enrollment

Registered

2015-01-20

Start date

2012-09-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.31

Interventions

Group 1: patients use the WatchPAT-200 for one night at home Group 2: patients use the Embletta PDS for one night at home

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: presence of previous diagnosed OSA (AHI >5 events/hour); current regular PAP use for at least 6 months

Exclusion criteria

Exclusion criteria: severe psychiatric disorders; severe neurological disorders; PAP noncompliance; history of peripheral vascular disease; finger deformity that precludes adequate WP200 sensor application

Design outcomes

Primary

Measure	Time frame
patient satisfaction with the home testing sleep devices regarding the comfort, assessed by a modified PSQ-18 questionnaire, which has to be completed after each measurement	—

Secondary

Measure	Time frame
efficacy of the WatchPAT in comparison to Embletta PDS in regard to AHI and ODI	—

Countries

Germany

Contacts

Public ContactStefanie Knorre

Charité-Universitätsmedizin Berlin, CCM-CC11, Interdisziplinäres Schlafmedizinisches Zentrum

stefanie.knorre@charite.de+4930450513122

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 6, 2026